Navigation Links
Updated Results from Phase 2 Trial Demonstrate Prolonged Hematologic Relapse-Free Survival of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia
Date:6/14/2010

ult patients with B precursor acute lymphoblastic leukemia.  Enrolled patients had sub-microscopic evidence of leukemic cells in the bone marrow following treatment with front-line chemotherapy, so called minimal residual disease (MRD). The primary endpoint of the study was MRD response. Key secondary endpoints included time to hematological relapse, time to molecular relapse and overall incidence and severity of adverse events.  Patients received 15 micrograms per meter squared per day of blinatumomab for 28 days followed by two weeks off therapy over a six week treatment cycle.  

Phase 2 Results

21 patients were treated in this study.  Of 20 evaluable patients, 80% (16 out of 20) achieved a complete MRD response. Among the 13 non-transplanted patients, there were eight patients with non-Ph+ or t(4;11) disease. For these eight patients the median time to hematological relapse has not been reached at a median follow-up of 480 days.  For a similar group of patients with MRD positive disease treated with chemotherapy by the German Multicenter Adult ALL Study Group (GMALL), a median time to hematological relapse of approximately 200 days from diagnosis has been reported(1).

Eight of the patients in the study received an allogeneic transplant after blinatumomab treatment, all of whom are alive and in remission, ranging up to 21 months.  Overall, blinatumomab was well-tolerated. The most common adverse events (any grade) were fever, decreases of immunoglobulins, and headache.  Two patients discontinued treatment due to adverse events; seizure and syncope, respectively, with both events being completely reversible.  

"Historical experience suggests that there is a high mortality rate among patients with ALL who receive a stem cell transplant," said Dr. Topp. "Notably, no deaths or relapses have been
'/>"/>

SOURCE Micromet, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Presents Updated IMPACT Results Confirming PROVENGE Improves Overall Survival in Patients With Metastatic Castrate-Resistant Prostate Cancer
2. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
3. Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety Trial Results
4. Newly Updated Pharmacy State Law Compendium Available
5. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
6. Roxane Laboratories, Inc. Updated Launch of Calcium Acetate Capsules, 667mg
7. Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
8. IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program
9. VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program
10. ORTHO EVRA(R) Prescribing Information Updated
11. Kosan Presents Updated Data on Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma at Ash
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... WAYNE, Pa. , April 1, 2015 /PRNewswire/ ... fully integrated specialty pharmaceutical company focused on developing, ... the pricing of an offering of $60.0 million ... due 2020 (the "notes") in a private placement ... under the Securities Act of 1933, as amended ...
(Date:4/1/2015)... SAN CLEMENTE, Calif. , April 1, 2015 /PRNewswire/ ... residents in the United States ... out amongst their resident colleagues. In its inaugural year, ... and 50 of the top nominations were narrowed to ... voting process that saw over 10,000 votes from colleagues ...
(Date:4/1/2015)... CREEK, Calif. , April 1, 2015  For ... huge difference.  When this is the case, having the ... No one understands this truth better than software solutions ... laboratory management software QATrax.  Recently, the company announced the ... very enthusiastic response from clients. ...
Breaking Medicine Technology:Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 7Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 2Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 3Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 4TraxStar Technologies Announces Latest QATrax Test Lab Management Software Now Available 2
(Date:4/1/2015)... SCI Solutions , the health ... announced that CEO Joel French will be a featured ... Exhibition in Chicago, April 12-16, 2015. French will ... Care Coordination Strategies ” with Northeast Georgia Health System ... More than 38,000 healthcare industry professionals are expected at ...
(Date:4/1/2015)... 01, 2015 Dr Roz Kamani, a ... is now offering her patients an opportunity to learn ... participate in “Beauty Days”, which is an exclusive VIP ... Kamani’s Kitsilano Skin Care Clinic. It is attended by ... about the latest products and services that are on ...
(Date:4/1/2015)... GrassrootsHealth, an international nonprofit public ... education (CME) courses about vitamin D . ... confident in measuring, prescribing, and tracking vitamin D ... CME courses, practitioners can apply for D*certification with ... are “Vitamin D, Sunshine, Optimal Health: Putting it ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Tempaper has ... a new virtual giving campaign that will raise critical ... people fighting muscle disease across the United States. , ... MDA through Tempaperdesigns.com will automatically receive free ... bring strength and urgently needed progress to children and ...
(Date:4/1/2015)... April 01, 2015 Like a mosaic ... the scientific understanding of the potential causes of rosacea. ... the National Rosacea Society (NRS) to educate the public ... facial disorder now estimated to affect more than 16 ... medical research on rosacea through its patient-funded research grants ...
Breaking Medicine News(10 mins):Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 2Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 3Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 4Health News:Dr Roz Kamani Now Offers Patients The Opportunity to Learn About Latest Products and Services 2Health News:GrassrootsHealth Launches CME Courses about Vitamin D 2Health News:GrassrootsHealth Launches CME Courses about Vitamin D 3Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 2Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 2Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 4Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 5
... Lancet (vol. 370, 11 August 2007) could lead to a ... It states that magnetic resonance imaging (MRI) is substantially more ... cancer . Up to now MRI was thought to be ... situ (DCIS) . Researchers at the University of Bonn have ...
... increase according to stage of disease, a new study ... CANCER, a peer-reviewed journal of the American Cancer Society, ... each stage, African American women had larger tumors and ... to nearby lymph nodes. After controlling for those clinical ...
... Today’s report from the Food and Drug Administration (FDA) ... forward in the agency’s effort to tackle the new ... The Task Force is clear and candid in acknowledging ... product category FDA regulates—from pharmaceuticals and devices to cosmetics ...
... by researchers at the University of Southern California, has brought ... the genetic changes that enable tumours to evade the body's ... breast and colorectal cancers, are significant to the field of ... tests and treatment for cancers. ,"The implication is ...
... baby to be produced from an egg, that was developed in ... ,The news provides hope for women who have ... help egg maturation in the ovaries themselves. ,The baby ... Canada after work at the McGill Reproductive Centre in Montreal. The ...
... community is struggling to come to terms with the aftermath of ... are emerging. ,An al-Qaeda leader in Iraq may ... when he reportedly told a British cleric in Baghdad that "those ... ,The cleric passed on details of the warning, but ...
Cached Medicine News:Health News:MRI finds breast cancer before it becomes dangerous 2Health News:MRI finds breast cancer before it becomes dangerous 3Health News:Survival differences by race most apparent in advanced stages of breast cancer 2Health News:Researchers Discover How Cancer Evades the Immune System 2Health News:First Baby Born from Eggs Matured and Frozen in the Lab 2Health News:Those Who Cure can Kill Dire Prophesy of the doctors Plot 2
... Inline Plus is an easy to use, full color ... monitor (either a computer or a television) sits on ... in. It has a built in SVGA adapter allowing ... the magnified image from the video magnifier is displayed ...
... portability together in one product. Flipperport consists ... color camera that captures the image, and ... the magnified image. This self contained, battery-operated ... and comfort. FlipperPort can easily connect with ...
... camera design enables people with low vision ... rotating the camera head, the user can ... any distance. Flipper is lightweight and can ... another. Simply roll the base and rotate ...
... vision to see objects at a distance, ... between. This battery operated system can be ... used as a desktop video magnifier when ... easy to use and requires no special ...
Medicine Products: